Haojun Xu
-
- Cancer-related molecular mechanisms research 7
-
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 4
-
- interferon and immune responses 3
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 4
- Cancer-related Molecular Pathways 3
-
- Cancer Mechanisms and Therapy 3
Haojun Xu
38 papers receiving 472 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 148
- Molecular Biology 293
- Immunology 68
- Oncology 82
- Agronomy and Crop Science 29
Countries citing papers authored by Haojun Xu
This map shows the geographic impact of Haojun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojun Xu more than expected).
Fields of papers citing papers by Haojun Xu
This network shows the impact of papers produced by Haojun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojun Xu. The network helps show where Haojun Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haojun Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 21 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 29 | |
| 17 | 2020 | 8 | |
| 18 | 2020 | 11 | |
| 19 | 2019 | 35 | |
| 20 | 2018 | 2 |
About Haojun Xu
Haojun Xu is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Small Animals, having authored 40 papers that have together received 473 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), interferon and immune responses (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Mechanisms and Therapy (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Cancer Research (148 citations), Molecular Biology (293 citations), Immunology (68 citations), Oncology (82 citations) and Agronomy and Crop Science (29 citations). Haojun Xu has collaborated with scholars based in China, Singapore and Egypt. Frequent co-authors include Hongping Xia, Guoren Zhou, Chengfei Zhang, Dan Fang, Hongjin Chen, Changmin Hu, Qi Sun, Chao Hu, Mo Xiao and Chengyun Yao. Their work appears in journals such as International Journal of Molecular Sciences, International Journal of Biological Sciences, Genomics, Scientific Reports and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.